December 15, 2023

UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments

David Robinson

Carolina Schinke, M.D.

Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…


December 14, 2023

UAMS Researcher Takes Aim at Drug-Resistant Myeloma

David Robinson

Fenghuang (Frank) Zhan, M.D., Ph.D.

  UAMS Myeloma Center researcher Fenghuang (Frank) Zhan, M.D., Ph.D., has spent his career in search of clues to help fight drug-resistant myeloma. His findings recently led him to establish a translational research project to beat drug-resistant myeloma for his 11-member myeloma research team, based at the UAMS Winthrop P. Rockefeller Cancer Institute. While the…


December 5, 2023

UAMS Researcher Receives $1.8 Million NIH Grant to Study Key Cell Processes in Energy Production

David Robinson

Huiliang Zhang, Ph.D., in his lab at UAMS.

LITTLE ROCK — Huiliang Zhang, Ph.D., at the University of Arkansas for Medical Sciences (UAMS), will use a $1.8 million grant from the National Institutes of Health (NIH) to study proton leak, a process within the body that affects metabolism and energy. Although scientists have been aware of proton leak for decades, Zhang said, little…


November 15, 2023

NIH Awards UAMS $1.54 Million to Tackle Brittle Bone Disease

David Robinson

Roy Morello, Ph.D., in his lab at UAMS.

LITTLE ROCK — A UAMS research team is using a $1.54 million grant from the National Institutes of Health (NIH) to support its goal of finding better treatments for osteogenesis imperfecta (OI), also known as brittle bone disease. The four-year award from the NIH National Heart, Lung, and Blood Institute will allow Roy Morello, Ph.D.,…


November 6, 2023

UAMS BioVentures Awarded Nearly $3 Million for Health Tech Entrepreneurship Program, Invited to White House

David Robinson

UAMS' Kevin Sexton, M.D. (left), president of BioVentures, chats with Donald “Don” Cravens Jr., under secretary of Commerce for the Minority Business Development Agency, during a ceremony at the White House to celebrate the Capital Readiness Program.

LITTLE ROCK — BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS) has secured a nearly $3 million grant from the U.S. Department of Commerce to support entrepreneurs from socially and economically disadvantaged backgrounds who are looking to develop health technology and health care businesses in Arkansas. The four-year $2,999,997 grant comes from…


October 20, 2023

Investigators Soak in Research Expo 2023’s Abundant Resources, Services

David Robinson

TRI's David Avery, senior director of Clinical Research Operations, and Carrie Cochran-Raglon, director of the UAMS Rural Research Network, talk with Lipika Sarangi, Ph.D. (right).

Alberto Ramirez, Ph.D., was excited to attend Research Expo 2023, with its 50 research services and resources on display. “As an early-career researcher, the event proved to be remarkably valuable as it allowed me to gain insight into the numerous resources offered by UAMS, including TRI, Research & Innovation, and more, which have the potential…


October 4, 2023

UAMS-Sponsored Health & Wellness Expo Delivers Free Screenings, Entertainment

David Robinson

Monica Smith, representing the UAMS Translational Research Institute, helped expo attendees join the ARresearch registry of potential research volunteers.

The 2023 Health and Wellness Expo, held Sept. 30 at the Statehouse Convention Center in downtown Little Rock, drew nearly 500 Arkansans for the half-day event. The free annual event, sponsored by UAMS Health and presented by the Arkansas Democrat-Gazette, was a big draw with free health screenings, presentations from UAMS physicians, and other health-related…


September 25, 2023

UAMS Division of Research and Innovation Engages Researchers at Orientation and Administrative Showcase

David Robinson

Christy Simecka, DACLAM, D.V.M., (front left), director, Division of Laboratory Animal Medicine, speaks with Susan Steelman, MLIS, AHIP; and (back left) Kerrey Roberto, director, Institutional Animal Care and Use Committee, talks to Dirk Haselow, M.D.

UAMS research faculty got to hear directly from Division of Research and Innovation staff during a fun and informative afternoon that featured brief presentations and concluded with a poster session and reception with drinks and light hors d’oeuvres.


August 21, 2023

UAMS’ Andrew Morris, Ph.D., Recognized with Prestigious VA Research Career Scientist Award

David Robinson

Andrew Morris, Ph.D., has received the prestigious Research Career Scientist Award from the VA Office of Research and Development.

UAMS and Veterans Affairs (VA) researcher Andrew Morris, Ph.D., has received the prestigious Research Career Scientist Award from the VA Office of Research and Development. The designation is for established researchers who have distinguished themselves through scientific achievements and substantial contributions to the VA research community. Morris is the UAMS Mehta/Stebbins Chair in Cardiovascular Research…


June 27, 2023

UAMS Bone Research Center Secures Second NIH Grant of Over $11 Million

David Robinson

Team members of the UAMS Center for Musculoskeletal Disease Research include:, front row: Jinhu Xiong M.D., Ph.D., Amy Sato, Ph.D., Jesus Delgado-Calle, Ph.D.; second row: Janeelle Whitfield, Melda Onal, Ph.D., Qiang Fu, M.D., Ph.D.; third row: Charles O’Brien, Ph.D., Maria Almeida, Ph.D., Roy Morello, Ph.D.; back row: Intawat Nookaew, Ph.D., Ha-neui Kim, Ph.D., and Elena Ambrogini, M.D., Ph.D.

LITTLE ROCK — A federal grant of more than $11 million will provide five additional years of support to the Center for Musculoskeletal Disease Research led by Charles O’Brien, Ph.D., at the University of Arkansas for Medical Sciences (UAMS). The $11.5 million Centers of Biomedical Research Excellence (COBRE) Phase 2 grant from the National Institute…



Previous page Next page